Daniel SontupeMarket Access
Matt TurnerPatient Affordability
Pat PurcellMeeting Engagement
Amy GilesIncreasing Engagement
Brenda SnowAuthentic Patient Voice
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
